Term Name:	1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine
Synonyms:	(2S,3S,4R)-1-[4-O-(4-fluorobenzyl)-alpha-D-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol, N-[(1S,2S,3R)-2,3-dihydroxy-1-[[[4-O-[(4-fluorophenyl)methyl]-alpha-D-galactopyranosyl]oxy]methyl]heptadecyl]hexacosanamide, N-[(2S,3S,4R)-1-({4-O-[(4-fluorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide, N-[(2S,3S,4R)-1-{[4-O-(4-fluorobenzyl)-alpha-D-galactopyranosyl]oxy}-3,4-dihydroxyoctadecan-2-yl]hexacosanamide, N-{(1S,2S,3R)-2,3-dihydroxy-1-[({4-O-[(4-fluorophenyl)methyl]-alpha-D-galactopyranosyl}oxy)methyl]heptadecyl}hexacosanamide, N-{(2S,3S,4R)-1-[4-O-(4-fluorobenzyl)-alpha-D-galactosyloxy]-3,4-dihydroxyoctadecan-2-yl}hexacosanamide
Definition:	A glycophytoceramide having a 4-O-(4-fluorobenzyl)-alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. One of a series of an extensive set of 4"-O-alkylated alpha-GalCer analogues evaluated (PMID:30556652) as invariant natural killer T-cell (iNKT) antigens.
Ontology:	ChEBI [CHEBI:145523]  ( EBI )